bioRxivMolecular BiologyPreprint
Acute kidney injury disrupts cardiac remodeling via SerpinA3N
Gowda S. Pramod, Stanley QuiD, Runze NiiD, Nadezhda N. ZheleznovaiD, Minghua LiiD, Nohely Hernandez, Lei WangiD, Nathan Hall, Bi Zhao, Justin GibbonsiD, Nilam Sanjib BanerjeeiD, Ganesh V. HaladeiD, Lucian LozonschiiD, Enyin LaiiD, Kristof WilliamsiD, Ruisheng LiuiD
Abstract
Cardiorenal syndrome type 3 (CRS-3) also known as acute reno-cardiac syndrome, refers to a condition where acute kidney injury (AKI) leads to acute cardiac dysfunction or injury. The underlying mechanisms have not been elucidated. In the current study, we examined the potential mechanisms for the development of myocardial pro-fibrotic factors and cardiac remodeling in C57BL/6J mice after AKI. The mice were subjected to bilateral pedicle clamping for 30 min followed by 24 h of reperfusion. Heart tissue was collected from control (Ctrl) and AKI mice and subjected to proteomic analysis by liquid chromatography-mass spectrometry (LC-MS) and differential mRNA expression analysis by RNA-seq. Cardiac tissue was collected to assess serine protease activity, RNA, protein and cytokine expression. The results indicate that AKI significantly upregulated SerpinA3N in the heart which was negatively correlated with serine protease (Granzyme B) activity. Further, AKI induced the development of several pro-fibrotic factors, induced mitochondrial dysfunction and increased inflammation. Finally, using H9C2 cells we demonstrated that inhibiting SerpinA3N with XAV939 increased Granzyme B activity. Thus, this study suggests that AKI leads to the development of pro-fibrotic factors in the heart and disrupts cardiac remodeling by SerpinA3N mediated inhibition of serine protease Granzyme B activity. Decreased SerpinA3N expression in the heart followed by AKI could lead to a more balanced extracellular matrix (ECM) composition in the heart with an alleviated pro-fibrotic response.
- organism: mouse
- assay: bulk RNA-seq
- assay: proteomics
- research focus: differential expression
- approach: statistical model
- approach: experimental assay
- Citations
- 0
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Kynurenic acid, a key L-tryptophan-derived metabolite, protects the heart from an ischemic damage
E. Bigelman, M. Pasmanik-Chor, … M. Entin Meer·bioRxiv·May 17, 2022
- Genetic Deletion of ASIC3 Alters Left Ventricular Remodeling and Autonomic Function After Myocardial Infarction in Mice
Karley Monaghan, David D. Gibbons, … Christopher J. Benson·Physiological ReportsPeer-reviewed·Mar 1, 2026
- Nicotinamide riboside: A promising therapy for MI-induced acute kidney injury by upregulating nicotinamide phosphoribosyltransferase-mediated NAD levels
Nada J. Habeichi, Ghadir Amin, … Fouad Anthony Zouein·Journal of the American Heart AssociationPeer-reviewed·Feb 26, 2025
- IL-17A Mediates Cardiac Hypertrophy in Chronic Kidney Disease through the IL-23/Th17 Axis.
Fumihiko Ogata, Shinsuke Hanatani, … Kenichi Tsujita·bioRxiv·Sep 23, 2026
- Annexin A1 tripeptide mimetic increases sirtuin-3 to augment mitochondrial function and limit ischemic kidney injury
H. Suliman, Q. Ma, … J. Privratsky·bioRxiv·Dec 11, 2020
- Fibroblast-specific inflammasome activation predisposes to atrial fibrillation
N. Li·bioRxiv·May 18, 2023